[Federal Register Volume 78, Number 91 (Friday, May 10, 2013)]
[Notices]
[Pages 27398-27399]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-11144]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Statement of Organization, Functions, and Delegations of 
Authority

    Part C (Centers for Disease Control and Prevention) of the 
Statement of Organization, Functions, and Delegations of Authority of 
the Department of Health and Human Services (45 FR 67772-76, dated 
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as 
amended most recently at 78 FR 25743-25746, dated May 2, 2013) is 
amended to reorganize the National Center for Immunization and 
Respiratory Diseases, Centers for Disease Control and Prevention.
    Section C-B, Organization and Functions, is hereby amended as 
follows:
    Delete in its entirety the titles and functional statements for the 
Influenza Division (CVGD) and insert the following:
    Influenza Division (CVGD). The Influenza Division (ID) improves 
global control and prevention of seasonal and novel influenza and 
improves influenza pandemic preparedness and response. In collaboration 
with domestic and global partners, the ID: (1) builds surveillance and 
response capacity; (2) monitors and assesses influenza viruses and 
illness; (3) improves vaccines and other interventions; and (4) applies 
research to provide science-based enhancement of prevention and control 
policies and programs.
    Office of the Director (CVGD1). (1) Provides vision, leadership and 
direction for the division; (2) fosters external partnerships and 
cross-cutting activities that support quality science and strong global 
partnerships; (3) provides leadership and guidance in policy 
formulation; (4) provides support for national and international 
capacity building programs; (5) provides technical expertise and 
leadership for national and international pandemic preparedness 
activities; and (6) provides technical expertise for communications, 
information technology, genomic sequencing, and reagent resources.
    Virology, Surveillance and Diagnosis Branch (CVGDB). (1) Conducts 
comprehensive antigenic, phenotypic, genotypic, structural, and 
evolutionary characterization of human and animal influenza viruses; 
(2) performs genetic and antigenic pandemic risk assessment of novel 
influenza viruses; (3) develops and evaluates novel and seasonal 
candidate vaccine viruses; (4) provides expert guidance on influenza 
vaccine virus selection; (5) develops methods to detect and 
characterize influenza viruses; and (6) trains and supports 
laboratories that perform influenza testing.
    Epidemiology and Prevention Branch (CVGDC). (1) Conducts 
surveillance and research activities to better understand the 
epidemiology of influenza; and (2) improves understanding of the 
effectiveness of influenza antiviral and vaccine programs.
    Immunology and Pathogenesis Branch (CVGDE). (1) Increases knowledge 
and improves understanding of immunity and immune correlates of 
protection; (2) develops and improves vaccines; (3) determines virus 
and host factors that impact virulence and transmission of influenza 
viruses; (4) conducts immunologic and virologic pandemic risk 
assessment of novel influenza viruses; and (5) trains and supports

[[Page 27399]]

laboratories that perform immunologic testing.

    Dated: May 2, 2013.
 Sherri A. Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2013-11144 Filed 5-9-13; 8:45 am]
BILLING CODE 4160-18-M